Gary Vanasse
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 5
- Erythropoietin and Anemia Treatment 4
- Multiple Myeloma Research and Treatments 3
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 4
- Virology top 10%
- Emergency Medicine top 5%
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 4
-
- Erythrocyte Function and Pathophysiology 6
-
- Click Chemistry and Applications 4
- Co-authors
- Nancy BerlinerDennis M. WillerfordPatrick ConcannonTodd S. PerlsteinReena L. PandeChristine M. DistècheYun WangBrenda Cartmel
- Cited by
- HematologyGeneticsVirology
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Gary Vanasse
32 papers receiving 800 citations
Peers
Comparison fields: 5 of 88
- Hematology 299
- Genetics 245
- Virology 69
- Emergency Medicine 132
- Pathology and Forensic Medicine 126
Countries citing papers authored by Gary Vanasse
This map shows the geographic impact of Gary Vanasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Vanasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Vanasse more than expected).
Fields of papers citing papers by Gary Vanasse
This network shows the impact of papers produced by Gary Vanasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Vanasse. The network helps show where Gary Vanasse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary Vanasse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 14 | |
| 2 | 2021 | 1 | |
| 3 | 2019 | 13 | |
| 4 | 2019 | 15 | |
| 5 | 2015 | 11 | |
| 6 | 2013 | 12 | |
| 7 | 2013 | 7 | |
| 8 | 2012 | 160 | |
| 9 | 2011 | 11 | |
| 10 | 2011 | 4 | |
| 11 | 2011 | 92 | |
| 12 | 2011 | 18 | |
| 13 | 2008 | 65 | |
| 14 | 2007 | 2 | |
| 15 | 2007 | 16 | |
| 16 | 2006 | 15 | |
| 17 | 2002 | 16 | |
| 18 | 1999 | 82 | |
| 19 | 1990 | 16 | |
| 20 | 1990 | 12 |
About Gary Vanasse
Gary Vanasse is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 32 papers that have together received 816 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Cancer Mechanisms and Therapy (4 papers), Click Chemistry and Applications (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Erythropoietin and Anemia Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (299 citations), Genetics (245 citations) and Virology (69 citations). Gary Vanasse has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Nancy Berliner, Dennis M. Willerford, Patrick Concannon, Todd S. Perlstein, Reena L. Pande, Christine M. Distèche, Yun Wang, Brenda Cartmel, Xiaomei Ma and Matthew S. Freiberg. Their work appears in journals such as Blood, British Journal of Haematology, Cancer Research, Journal of Clinical Investigation and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.